Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0820
+0.0020 (2.50%)
At close: Sep 8, 2026
RMTG Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.32 | 0.96 | 1.17 | 0.53 | 1.65 | 2.98 |
Cash & Short-Term Investments | 1.32 | 0.96 | 1.17 | 0.53 | 1.65 | 2.98 |
Cash Growth | -18.02% | -17.94% | 119.74% | -67.75% | -44.77% | 6902.69% |
Receivables | 0.11 | 0.04 | 0.02 | 0.02 | 0.05 | 0.02 |
Inventory | 0.48 | 0.16 | 0.01 | - | - | - |
Prepaid Expenses | 0.37 | 0.06 | 0.05 | 0.02 | - | 0.02 |
Other Current Assets | - | - | - | - | - | 0 |
Total Current Assets | 2.28 | 1.22 | 1.25 | 0.57 | 1.69 | 3.02 |
Property, Plant & Equipment | 1.73 | 1.49 | 0.73 | 0.36 | 0.22 | 0.02 |
Goodwill | 1.68 | 1.68 | 1.68 | 1.68 | 5.81 | 5.81 |
Other Intangible Assets | 0.01 | 0.06 | 0.16 | 0.26 | 0.35 | 0.45 |
Other Long-Term Assets | 0.15 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
Total Assets | 5.85 | 4.49 | 3.82 | 2.88 | 8.08 | 9.31 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.08 | 0.35 | 0.56 | 0.42 | 0.25 | 0.18 |
Accrued Expenses | 19.62 | 16.56 | 10.5 | 6.6 | 4.66 | 2.13 |
Current Portion of Long-Term Debt | 19.09 | 16.94 | 17.77 | 15.22 | 7.05 | 1.53 |
Current Portion of Leases | 0.16 | 0.22 | 0.06 | 0 | 0.03 | - |
Other Current Liabilities | 3.67 | 2.76 | 0.06 | 0 | 0.02 | 0.38 |
Total Current Liabilities | 42.61 | 36.82 | 28.97 | 22.25 | 12 | 4.22 |
Long-Term Debt | 2 | 2 | 2 | 2.43 | 8.06 | 11.84 |
Long-Term Leases | 0.49 | 0.41 | 0.21 | - | 0 | - |
Total Liabilities | 45.11 | 39.23 | 31.18 | 24.67 | 20.06 | 16.06 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 40.21 | 40.61 | 40.18 | 40.18 | 40.18 | 39.9 |
Retained Earnings | -79.48 | -75.37 | -67.55 | -61.99 | -52.18 | -46.67 |
Comprehensive Income & Other | - | - | - | - | - | -0 |
Total Common Equity | -39.26 | -34.75 | -27.36 | -21.8 | -11.98 | -6.76 |
Shareholders' Equity | -39.26 | -34.75 | -27.36 | -21.8 | -11.98 | -6.76 |
Total Liabilities & Equity | 5.85 | 4.49 | 3.82 | 2.88 | 8.08 | 9.31 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 21.74 | 19.57 | 20.05 | 17.65 | 15.14 | 13.37 |
Net Cash (Debt) | -20.42 | -18.61 | -18.88 | -17.12 | -13.5 | -10.39 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.58 | -1.47 | -1.51 | -1.38 | -1.10 | -0.91 |
Filing Date Shares Outstanding | 13.74 | 13.14 | 12.54 | 12.49 | 12.44 | 12.16 |
Total Common Shares Outstanding | 13.74 | 13.14 | 12.54 | 12.49 | 12.44 | 12.09 |
Working Capital | -40.33 | -35.6 | -27.72 | -21.67 | -10.3 | -1.2 |
Book Value Per Share | -2.86 | -2.64 | -2.18 | -1.74 | -0.96 | -0.56 |
Tangible Book Value | -40.95 | -36.49 | -29.2 | -23.73 | -18.14 | -13.02 |
Tangible Book Value Per Share | -2.98 | -2.78 | -2.33 | -1.90 | -1.46 | -1.08 |
Machinery | 0.52 | 0.43 | 0.18 | 0.17 | 0.15 | 0.07 |
Leasehold Improvements | 1.33 | 1.05 | 0.7 | 0.5 | 0.13 | - |